Submit your RFI/RFP
Submit your RFI/RFP
Back
Regulatory Affairs
Back
Pharmacovigilance
Pharmacovigilance
Integrated Safety Management from Development to Market
Delivering end-to-end pharmacovigilance services to ensure the highest standards of drug safety and regulatory compliance globally.
Back
Local Affiliate Services
Back
Company
Company
Excellence in Pharmacovigilance & Regulatory Affairs
Superior quality pharmacovigilance and regulatory affairs services helping the pharmaceutical industry make safe and effective healthcare products available worldwide.
  • Home
  • Insights
  • Financial Times names Insuvia as One of Europe’s Fastest Growing Companies

Financial Times names Insuvia as One of Europe’s Fastest Growing Companies

08 March, 2023 Regulatory Affairs Pharmacovigilance Company news
Financial Times names Insuvia as One of Europe’s Fastest Growing Companies

Insuvia as One of Europe’s Fastest Growing Companies! We are thrilled to announce that we have secured a position on the Financial Times FT1000 list of the fastest-growing companies in Europe by ranking 367th place. The FT1000 list is a highly coveted and widely respected ranking of European companies that have achieved significant growth over the last few years.

Insuvia’s placement on this year’s FT1000 list is a testimony to the company’s relentless focus on customer service and quality. Our inclusion in FT 1000 list is a proud moment for the company and its employees, and it serves as a reminder of the power of hard work and a customer-first mindset.

As we continue to grow and expand our reach there is no doubt that it will continue to make a significant impact on the healthcare industry and beyond.

If you have any questions don’t hesitate to contact us.

 

Contact
Contact us for more information
Contact type